Forcing a vaccine on people that neither want, nor need
Moderna’s COVID-19 vaccine is competing with Pfizer vaccine for the market share. Belgium study claims it produced double amount of Ab.
Moderna’s COVID-19 vaccine is competing with Pfizer vaccine for the market share. Belgium study claims it produced double amount of Ab.
Dutch and Germany researchers show COVID19 vaccine induces complex reprogramming of innate immune responses may be overlooked in the development and use of mRNA-based vaccines.
New research found that natural immunity offers exponentially more protection than COVID-19 vaccines.
A new report appears to cast doubt on the immuno-response of vaccine immunity.
Mass vaccination in the middle of a pandemic is prone to promoting selection and adaptation of immune escape variants that are featured by increasing infectiousness and resistance to spike protein (S)-directed antibodies.
Early data from Israel shows natural immunity wanes with time. People who recovered from Covid may face lower risk from delta.
Although deliberate infection is not recommended, an Israeli study shows that the natural immune protection that develops after a Covid19 infection offers much more of a shield against the Delta variant than two doses of the Pfizer vaccine.
A newly published World Health Organization (WHO) report urges the transition to digital certification of vaccine status, presenting implementation strategies for member states.
An Ohio judge on Monday ordered a hospital to treat at COVID-19 patient with ivermectin — an unproven virus treatment and livestock dewormer — going against CDC and FDA recommendations.
The risk of rare side effects like myocarditis and pericarditis – types of heart inflammation that are potentially deadly in some patients – was at least 2.5x higher in the Moderna jab than in its main competitor, produced by Pfizer-BioNTech.